The age-old advice to "trust your gut" could soon take on new meaning for people diagnosed with Parkinson's disease, thanks ...

Buntanetap significantly improves cognition in all Parkinson’s patients, with those exhibiting Alzheimer’s co-pathology ...

Annovis Bio rises after Phase 3 data show buntanetap halted decline in Parkinson's patients, with results in those with amyloid co-pathology.

Feb. 4—MOULTRIE — Colquitt Regional Medical Center and Vereen Rehabilitation Center now offer LSVT Big and LSVT Loud — an innovative treatment designed for patients with Parkinson's disease and ...

Karolinska Development AB ( ($SE:KDEV) ) just unveiled an update. Karolinska Development AB’s portfolio company, Umecrine Cognition, has published ...

November 17, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has published data in the scientific journal Neuropharmacology, ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Functional neurological disorder (FND) describes symptoms like paralysis, seizures, and tremor-related to a disorder of nervous system functioning rather than conditions like multiple sclerosis or ...

A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...

Functional neurological disorder (FND) describes symptoms like paralysis, seizures, and tremor-related to a disorder of nervous system functioning rather than conditions like multiple sclerosis or ...